Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Fursov

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Assay and Drug Development Technologies|February 8, 2011
Development and utilization of activated STAT3 detection assays for screening a library of secreted proteinsNatalie Fursov, Irina V Gates, Tadas Panavas, et al.
International Journal of Molecular Sciences|October 2, 2014
EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild type NSCLC cell lineDaniel J Ranayhossaini, Jin Lu, John Mabus, et al.
Assay and Drug Development Technologies|March 31, 2005
Improving consistency of cell-based assays by using division-arrested cellsNatalie Fursov, Mei Cong, Mark Federici, et al.
Assay and Drug Development Technologies|November 25, 2005
Improving high-content-screening assay performance by using division-arrested cellsChandrasekaran Vasudevan, Natalie Fursov, Patrick Maunder, et al.
Molecular and Cellular Biology|December 30, 2006
Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinaseJames G Greger, Natalie Fursov, Neil Cooch, et al.
Hybridoma (2005)|May 3, 2011
Generation and characterization of rat anti-mouse ST2L monoclonal antibodiesNatalie Fursov, Erin Johnston, Karen Duffy, et al.
Molecular Immunology|June 14, 2016
Monoclonal antibodies targeting ST2L Domain 1 or Domain 3 differentially modulate IL-33-induced cytokine release by human mast cell and basophilic cell linesNatalie Fursov, Jin Lu, Catherine Healy, et al.
The American Journal of Pathology|June 7, 2011
Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma modelHemanth Ramaprakash, Takehiko Shibata, Karen E Duffy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Assay and Drug Development Technologies|February 8, 2011
Development and utilization of activated STAT3 detection assays for screening a library of secreted proteinsNatalie Fursov, Irina V Gates, Tadas Panavas, et al.
International Journal of Molecular Sciences|October 2, 2014
EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild type NSCLC cell lineDaniel J Ranayhossaini, Jin Lu, John Mabus, et al.
Assay and Drug Development Technologies|March 31, 2005
Improving consistency of cell-based assays by using division-arrested cellsNatalie Fursov, Mei Cong, Mark Federici, et al.
Assay and Drug Development Technologies|November 25, 2005
Improving high-content-screening assay performance by using division-arrested cellsChandrasekaran Vasudevan, Natalie Fursov, Patrick Maunder, et al.
Molecular and Cellular Biology|December 30, 2006
Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinaseJames G Greger, Natalie Fursov, Neil Cooch, et al.
Hybridoma (2005)|May 3, 2011
Generation and characterization of rat anti-mouse ST2L monoclonal antibodiesNatalie Fursov, Erin Johnston, Karen Duffy, et al.
Molecular Immunology|June 14, 2016
Monoclonal antibodies targeting ST2L Domain 1 or Domain 3 differentially modulate IL-33-induced cytokine release by human mast cell and basophilic cell linesNatalie Fursov, Jin Lu, Catherine Healy, et al.
The American Journal of Pathology|June 7, 2011
Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma modelHemanth Ramaprakash, Takehiko Shibata, Karen E Duffy, et al.
Pageof 1